A randomized, 5-arm dose finding study with a mite allergoid SCIT in allergic rhinoconjunctivitis patients
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A randomized, 5-arm dose finding study with a mite allergoid SCIT in allergic rhinoconjunctivitis patients
Authors
Keywords
-
Journal
ALLERGY
Volume 71, Issue 7, Pages 967-976
Publisher
Wiley
Online
2016-02-11
DOI
10.1111/all.12860
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In vivodiagnosis of allergic diseases-allergen provocation tests
- (2015) I. Agache et al. ALLERGY
- A randomized DBPC trial to determine the optimal effective and safe dose of a SLIT-birch pollen extract for the treatment of allergic rhinitis: results of a phase II study
- (2015) O. Pfaar et al. ALLERGY
- Environmental exposure chambers in allergen immunotherapy trials: Current status and clinical validation needs
- (2015) Karen Rösner-Friese et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper
- (2014) O. Pfaar et al. ALLERGY
- Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis
- (2014) Karl-Christian Bergmann et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Immunological comparison of allergen immunotherapy tablet treatment and subcutaneous immunotherapy against grass allergy
- (2013) K. Aasbjerg et al. CLINICAL AND EXPERIMENTAL ALLERGY
- An evidence-based analysis of house dust mite allergen immunotherapy: A call for more rigorous clinical studies
- (2013) Moises A. Calderon et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The placebo effect in allergen-specific immunotherapy trials
- (2013) Annemie Narkus et al. Clinical and Translational Allergy
- Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients
- (2013) Juliane Rieker-Schwienbacher et al. Clinical and Translational Allergy
- The average Adjusted Symptom Score, a new primary efficacy end-point for specific allergen immunotherapy trials
- (2011) J.-M. Grouin et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Effect of One-Year Subcutaneous and Sublingual Immunotherapy on Clinical and Laboratory Parameters in Children with Rhinitis and Asthma: A Randomized, Placebo-Controlled, Double-Blind, Double-Dummy Study
- (2011) Ayfer Yukselen et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Mechanisms of allergen-specific immunotherapy
- (2011) Cezmi A. Akdis et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficacy and Safety of a Glutaraldehyde-Modified House Dust Mite Extract in Allergic Rhinitis
- (2010) Herbert Riechelmann et al. American Journal of Rhinology & Allergy
- Efficacy of Desloratadine in Persistent Allergic Rhinitis – A GA2LEN Study
- (2010) Jean Bousquet et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System
- (2010) Linda Cox et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started